FibroBiologics, Inc.
FBLG
$0.86
-$0.04-4.44%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/31/2025
-
GuruFocus
3/31/2025
-
Globe Newswire
3/27/2025
-
GuruFocus
3/27/2025
-
Globe Newswire
3/21/2025
-
GuruFocus
3/21/2025
-
Globe Newswire
3/12/2025
-
Ticker Report
3/4/2025
-
GuruFocus
3/4/2025
-
The Fly
3/4/2025
-
Globe Newswire
2/27/2025
-
GuruFocus
2/27/2025
-
The Fly
2/27/2025
-
Globe Newswire
2/5/2025
-
GuruFocus
2/5/2025
-
Globe Newswire
2/4/2025
-
Simply Wall St
2/3/2025
-
The Fly
1/30/2025
-
GuruFocus
1/24/2025
-
TipRanks Financial Blog
1/24/2025
-
Ticker Report
1/9/2025
-
MarketBeat
12/30/2024
-
GuruFocus
12/30/2024
-
Globe Newswire
12/30/2024
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, November 12, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
281 651 5150
Address
455 East Medical Center Boulevard
Houston, TX 77598
Houston, TX 77598
Country
Year Founded
Business Description
Sector
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and...
more
